Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0NF5J
|
|||
| Former ID |
DCL001182
|
|||
| Drug Name |
EZN-2968
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1 | [1] | |
| Company |
Santaris Pharma A/S
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 2011 Pipeline of Santaris Pharma. | |||
| REF 2 | Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1), in patients with refractory solid tumors.Cancer Chemother Pharmacol.2014 Feb;73(2):343-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.